| Literature DB >> 26006242 |
Sieglinde Zelzer1, Harald Mangge2, Sabine Pailer3, Herwig Ainoedhofer4, Petra Kieslinger5, Tatjana Stojakovic6, Hubert Scharnagl7, Florian Prüller8, Daniel Weghuber9,10, Christian Datz10,11, Johannes Haybaeck12, Barbara Obermayer-Pietsch13, Christian Trummer14, Johanna Gostner15, Hans-Jürgen Gruber16.
Abstract
Metabolic dysfunctions might play a crucial role in the pathophysiology of thyroid dysfunctions. This study aimed to investigate the impact of a controlled diet (normal versus high fat feeding) on hypothyroid and hyperthyroid Sprague Dawley rats. Female Sprague Dawley rats (n = 66) were grouped into normal diet (n = 30) and high-fat diet (n = 36) groups and subdivided into controls, hypothyroid and hyperthyroid groups, induced through propylthiouracil or triiodothyronine (T3) treatment, respectively. After 12 weeks of treatment metabolic parameters, such as oxidized LDL (oxLDL), malondialdehyde (MDA), 4-hydroxynonenal (HNE), the lipid profile, body weight and food intake parameters were analyzed. Successfully induced thyroid dysfunctions were shown by T3 levels, both under normal and high fat diet. Thyroid dysfunctions were accompanied by changes in calorie intake and body weight as well as in the lipid profile. In detail, hypothyroid rats showed significantly decreased oxLDL levels, whereas hyperthyroid rats showed significantly increased oxLDL levels. These effects were seen under high fat diet and were less pronounced with normal feeding. Taken together, we showed for the first time in female SD rats that only hyper-, but not hypothyroidism, is associated with high atherogenic oxidized LDL irrespective of normal or high-fat diet in Sprague Dawley rats.Entities:
Keywords: Sprague Dawley rats; fat feeding; hyperthyroidism; hypothyroidism; metabolic dysfunction; oxidized LDL
Mesh:
Substances:
Year: 2015 PMID: 26006242 PMCID: PMC4463724 DOI: 10.3390/ijms160511689
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Characteristics of female SD rats after a 12-week treatment.
| Normal Diet Group ( | High Fat Diet Group ( | |||||
|---|---|---|---|---|---|---|
| Control ( | Hypothyroid ( | Hyperthyroid ( | Control ( | Hypothyroid ( | Hyperthyroid ( | |
| Body weight change (g) | 36 ± 24 | −35 ± 8 *** | 31 ± 7 | 56 ± 24 | −42 ± 16 *** | 49 ± 17 †† |
| Body weight change (%) | 14 ± 10 | −13 ± 2 *** | 12 ± 3 | 21 ± 9 | −15 ± 5 *** | 19 ± 7 |
| Food intake/rate/day (g) | 19 | 10 | 30 | 13 | 8 | 18 |
| Calorie intake/rat/day (kcal) | 49 | 26 | 80 | 61 | 38 | 87 |
| T3 (pg/mL) | 417 ± 85 | 269 ± 74 ** | 951 ± 454 ** | 450 ± 58 | 446 ± 176 †† | 1708 ± 1447 |
| Oxidized LDL (ng/mL) | 6.1 ± 2.5 | 2.6 ± 1.3 ** | 8.8 ± 3.0 * | 6.9 ± 1.6 | 2.1 ± 1.3 *** | 9.5 ± 3.0 * |
| MDA (nmol/mL) | 1.4 ± 0.2 | 1.4 ± 0.3 | 1.0 ± 0.2 *** | 1.0 ± 0.1 ººº | 0.7 ± 0.1 ††† | 1.0 ± 0.3 |
| HNE (nmol/mL) | 0.09 ± 0.02 | 0.09 ± 0.03 | 0.12 ± 0.05 | 0.08 ± 0.02 | 0.07 ± 0.02 | 0.11 ± 0.04 |
| Triglyceride (mg/dL) | 62 ± 8 | 46 ± 4 *** | 61 ± 36 | 50 ± 12 º | 32 ± 6 ††† | 88 ± 14 |
| Cholesterol (mg/dL) | 86 ± 13 | 87 ± 14 | 69 ± 17 * | 81 ± 14 | 185 ± 23 ††† | 64 ± 13 |
| Free cholesterol (mg/dL) | 24 ± 4 | 26 ± 5 | 19 ± 6 * | 20 ± 5 | 59 ± 8 ††† | 18 ± 7 |
| Phospholipids (mg/dL) | 156 ± 15 | 120 ± 19 ** | 141 ± 21 | 139 ± 22 | 209 ± 21 ††† | 129 ± 26 |
| Free fatty acids (mmol/L) | 1.1 ± 0.2 | 0.7 ± 0.2 ** | 1.0 ± 0.3 | 0.8 ± 0.1 ºº | 0.5 ± 0.1 | 1.2 ± 0.5 |
| HDL cholesterol (mg/dL) | 44 ± 5 | 39 ± 6 | 41 ± 7 | 44 ± 5 | 66 ± 5 ††† | 40 ± 9 |
MDA: malondialdehyde; HNE: 4-hydroxynonenal; Data are presented as means ± standard deviations * p < 0.05, ** p < 0.01, *** p < 0.001 compared to appropriate control; º p < 0.05, ºº p < 0.01, ººº p < 0.001 compared to normal diet control group; †† p < 0.01, ††† p < 0.001 compared to appropriate normal diet group.
Figure 1Box and Whisker Blot of oxidized LDL. Grey bars indicate normal diet and black bars indicate high fat diet. * p < 0.05 compared to appropriate diet control group; º p < 0.05 compared to normal diet control group.